PA5108

Australia’s PolyActiva Opens Fort Worth Office With New Locally Based CEO, CFO, and CSO

by | Jul 17, 2025
After selling Fort Worth-based Eyevance Pharmaceuticals for $225 million in 2020, Jerry St. Peter is back in the company-building business—now as CEO of Melbourne-based PolyActiva. He’s bringing his former top team with him as the company ramps up U.S. clinical trials of its glaucoma treatment.
MORE